Quick Answer
Emmaus Life Sciences, Inc. reported Total Revenue of $12.45 million for fiscal year 2025.
Emmaus Life Sciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $12.45M | -25.2% |
| 2024 | $16.65M | -43.7% |
| 2023 | $29.60M | +60.9% |
| 2022 | $18.39M | -10.8% |
| 2021 | $20.61M | -11.0% |
| 2020 | $23.17M | +1.8% |
| 2019 | $22.75M | +38.2% |
| 2018 | $16.46M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.38M | -38.3% | +19.9% |
| June 30, 2025 | $2.82M | -47.6% | +17.1% |
| March 31, 2025 | $2.41M | -4.0% | -56.1% |
| September 30, 2024 | $5.48M | +9.2% | +1.9% |
| June 30, 2024 | $5.38M | -50.0% | +114.6% |
| March 31, 2024 | $2.51M | -62.9% | -50.1% |
| September 30, 2023 | $5.02M | +1.6% | -53.4% |
| June 30, 2023 | $10.76M | +151.0% | +59.3% |
- Emmaus Life Sciences, Inc. showed a decrease of -25.2% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, Emmaus Life Sciences, Inc.’s total revenue has declined by 24.3% (from $16.46 million to $12.45 million).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: